• 1
    Slocombe RF, Slauson DO. Invasive pulmonary aspergillosis of horses: An association with acute enteritis. Vet Pathol 1988;25:277281.
  • 2
    Hattel AL, Drake TR, Anderholm BJ, et al. Pulmonary aspergillosis associated with acute enteritis in a horse. J Am Vet Med Assoc 1991;199:589590.
  • 3
    Sweeney CR, Habecker PL. Pulmonary aspergillosis in horses: 29 cases (1974–1997). J Am Vet Med Assoc 1999;214:808811.
  • 4
    Blue J, Perdrizet J, Brown E. Pulmonary aspergillosis in a horse with myelomonocytic leukemia. J Am Vet Med Assoc 1987;190:15621564.
  • 5
    Giguere S, Polkes AC. Immunologic disorders in neonatal foals. Vet Clin North Am Equine Pract 2005;21:241272.
  • 6
    Carrasco L, Mendez A, Jensen HE. Chronic bronchopulmonary aspergillosis in a horse with Cushing's syndrome. Mycoses 1996;39:443447.
  • 7
    Breshears MA, Holbrook TC, Haak CE, et al. Pulmonary aspergillosis and ischemic distal limb necrosis associated with enteric salmonellosis in a foal. Vet Pathol 2007;44:215217.
  • 8
    Burgos A, Zaoutis TE, Dvorak CC, et al. Pediatric invasive aspergillosis: A multicenter retrospective analysis of 139 contemporary cases. Pediatrics 2008;121:e1286e1294.
  • 9
    Perryman LE, McGuire TC, Crawford TB. Maintenance of foals with combined immunodeficiency: Causes and control of secondary infections. Am J Vet Res 1978;39:10431047.
  • 10
    Thomas KE, Owens CM, Veys PA, et al. The radiological spectrum of invasive aspergillosis in children: A 10-year review. Pediatr Radiol 2003;33:453460.
  • 11
    Greene RE, Schlamm HT, Oestmann JW, et al. Imaging findings in acute invasive pulmonary aspergillosis: Clinical significance of the halo sign. Clin Infect Dis 2007;44:373379.
  • 12
    Gefter WB, Albelda SM, Talbot GH, et al. Invasive pulmonary aspergillosis and acute leukemia. Limitations in the diagnostic utility of the air crescent sign. Radiology 1985;157:605610.
  • 13
    Miller Jr WT, Sais GJ, Frank I, et al. Pulmonary aspergillosis in patients with AIDS. Clinical and radiographic correlations. Chest 1994;105:3744.
  • 14
    Habicht JM, Matt P, Passweg JR, et al. Invasive pulmonary fungal infection in hematologic patients: Is resection effective? Hematol J 2001;2:250256.
  • 15
    Habicht JM, Preiss M, Passweg J, et al. Invasive pulmonary aspergillosis: Effects of early resection in a neutropenic rat model. Eur J Cardiothorac Surg 2002;22:728732.
  • 16
    Matt P, Bernet F, Habicht J, et al. Short- and long-term outcome after lung resection for invasive pulmonary aspergillosis. Thorac Cardiovasc Surg 2003;51:221225.
  • 17
    Doganis D, Baka M, Pourtsidis A, et al. Successful combination of antifungal agents and surgical resection for pulmonary aspergillosis in a child with Hodgkin disease: Review of the literature. Pediatr Hematol Oncol 2007;24:631638.
  • 18
    Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002;347:408415.
  • 19
    Colitz CM, Latimer FG, Cheng H, et al. Pharmacokinetics of voriconazole following intravenous and oral administration and body fluid concentrations of voriconazole following repeated oral administration in horses. Am J Vet Res 2007;68:11151121.
  • 20
    Davis JL, Salmon JH, Papich MG. Pharmacokinetics of voriconazole after oral and intravenous administration to horses. Am J Vet Res 2006;67:10701075.
  • 21
    Latimer FG, Colitz CM, Campbell NB, et al. Pharmacokinetics of fluconazole following intravenous and oral administration and body fluid concentrations of fluconazole following repeated oral dosing in horses. Am J Vet Res 2001;62:16061611.
  • 22
    Sabatelli F, Patel R, Mann PA, et al. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts. Antimicrob Agents Chemother 2006;50:20092015.